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ABSTRACT 
Blackcurrants are rich in polyphenolic glycosides called anthocyanins, which may 
inhibit postprandial glycemia. The aim was to determine the dose-dependent effects 
of blackcurrant extract on postprandial glycemia. Men and postmenopausal women 
(14 M, 9 W, mean age 46 y, SD 14) were enrolled into a randomized, double-blind, 
crossover trial. Low sugar fruit drinks containing blackcurrant extract providing150 
mg (L-BE), 300 mg (M-BE) and 600 mg (H-BE) total anthocyanins or no blackcurrant 
extract (CON) were administered immediately before a high-carbohydrate meal. 
Plasma glucose, insulin, and incretins (GIP and GLP-1) were measured 0-120 min, 
and plasma 8-isoprostane F2 together with arterial stiffness by digital volume pulse 
(DVP) were measured at 0 and 120 min. Early plasma glucose response was 
significantly reduced following H-BE (n = 22), relative to CON, with a mean 
difference (95% CI) in area over baseline (AOB) 0-30min of -0.34 mmol/L.h (-0.56, -
0.11, P <0.005); there were no differences between the intermediate doses and 
placebo. Plasma insulin concentrations (AOB 0-30 min) were similarly reduced. 
Plasma GIP concentrations (AOB 0-120 min) were significantly reduced following H-
BE, with a mean difference of -46.6 ng/L.h (-66.7,-26.5, P <0.0001) compared to 
CON. Plasma GLP-1 concentrations were reduced following H-BE at 90 min. There 
were no effects on 8-isoprostane F2, or vascular function. Consumption of 
blackcurrant extract in amounts roughly equivalent to 100 g blackcurrants reduced 
postprandial glycemia, insulinemia, and incretin secretion, which suggests that 
inclusion of blackcurrant polyphenols in foods may provide cardio-metabolic health 
benefits. This trial was registered at clinicaltrials.gov as NCT01706653.   
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1. Introduction 
Evidence is emerging that fruit polyphenols may have wide ranging beneficial effects on 
vascular and metabolic health [1]. Among the long list of potential fruit bioactives are the 
anthocyanins: polyphenolic glycosides belonging to the flavonoid family that vividly pigment 
berries and other plant foods. The aglycones of anthocyanins, anthocyanidins, include 
delphinidin, petunidin, cyanidin, malvidin, pelargonidin and peonidin. Glycosylation can involve 
glucose, galactose, rhamnose and arabinose or various combinations of these sugars. There 
may also be acylation with p-coumaric, ferulic, caffeic, sinapic, malonic, acetic or p-
hydroxybenzoic acids. Blackcurrants are particularly rich in delphinidin-3-rutinoside, cyanidin-3-
rutinoside, delphinidin-3-glucoside and cyanidin-3-glucoside, as well as condensed tannins 
(proanthocyanidins), oligomeric and polymeric chains of flavan-3-ols [2].  
Since dietary anthocyanins are derived from a relatively narrow range of specific foods, average 
intakes are difficult to establish from short-term food records. Mean estimates from food 
frequency questionnaires are 12.5 to 15.2 mg/d (IQR: 4.6-19.3 mg/d) in US middle-aged and 
older men and women, mainly from strawberry and blueberry consumption [3], and 17.7 mg/d 
(IQR: 8.4-23.6 mg/d) in UK women, mainly from grapes, pears, wine, strawberries and 
raspberries [4]. Epidemiological studies have reported that higher intakes of anthocyanins are 
associated with a reduced risk of hypertension and arterial stiffness [3, 4], and lower markers of 
systemic inflammation and insulin resistance [5]. In support of a beneficial effect of habitual 
anthocyanin intake on insulin resistance, higher intakes of berries (4 d food records) at baseline 
were associated with a reduced risk of type 2 diabetes at follow up (mean 19.3 y) in a Finnish 
prospective cohort of middle-aged and older men [6]. 
Ingestion of berry anthocyanins may have rapid effects on blood glucose levels by delaying 
carbohydrate digestion and inhibiting the rate of glucose absorption across the intestine [7, 8, 9, 
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10, 11, 12, 13], although proanthocyanidins are likely to be responsible for inhibition of -
amylase [13]. Randomized controlled trials suggest that consuming whole berries may help 
control blood glucose concentrations [14, 15, 16, 17, 18], but the active component is not yet 
clear. 
The present study set out to test the hypothesis that drinks containing an anthocyanin-rich 
blackcurrant extract would decrease postprandial peak glucose concentrations following a 
carbohydrate meal in a dose-dependent fashion, compared with a matched placebo drink. 
Secondary outcomes included plasma insulin, GIP and GLP-1 response. Reducing postprandial 
glycemia may reduce markers of oxidative stress and endothelial function [19, 20]; therefore 
changes in indices of vascular function and plasma 8-isoprostane F2 concentrations were also 
evaluated.  
2. Subjects and methods  
2.1 Subjects 
Ethical approval for the study was obtained from King’s College London research ethics 
committee (reference BDM/11/12-88), and written informed consent was given by participants. 
The trial was carried out in accordance with the Declaration of Helsinki of 1975 as revised in 
1983, and registered at ClinicalTrials.gov (NCT01706653). The aim was to recruit 22 subjects, 
allowing for 4 drop-outs to complete 18 subjects, which would enable detection of a 1.6 mmol/L 
difference in glucose incremental Cmax, assuming 80% power (estimated from Torronen et al. 
[17] treatment group SD of 1.3 to 1.5 mmol/L for Cmax, rho=0.1 ), using a paired t-test with an 
alpha 0.017 (allowing for 3-waycomparisons). Social networking website advertisements and a 
circular email within King’s College London were used for recruitment, which was initiated in 
August 2012. A participant information sheet was provided to volunteers who expressed 
interest. Participants, recruited from King’s College London and from the general public in the 
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London area, attended the Metabolic Research Unit at the Diabetes & Nutritional Sciences 
Division, King’s College London in a fasting state for a screening appointment which included 
the measurement of height, weight, waist circumference, % body fat (by bioelectrical impedance 
using the TanitaTM Body Composition Analyser), seated blood pressure, liver function tests, 
glucose, lipid profile and haematology. A small remuneration was given for participation in the 
study. Inclusion criteria were: healthy men aged 20-60 y and postmenopausal women aged 45-
60 y, BMI 18-35 kg/m2, able to understand the information sheet and willing to comply with 
study protocol, and able to give written informed consent. Women aged 45 y or older who 
reported not having had a period for 12 months or longer were defined as postmenopausal. 
Exclusion criteria were as follows: phenylketonuria; allergy, hypersensitivity or intolerance to 
any foods/food ingredients; participation in another clinical trial; those with full blood counts and 
liver function tests outside of the normal range; current smokers or those who gave up smoking 
within the last 6 months; reported medical history of cardiovascular disease, cancer, liver, 
kidney or bowel disease; fasting glucose ≥7.1 mmol/L or uncontrolled type 2 diabetes; presence 
of gastrointestinal disorder or use of drug which is likely to alter gastrointestinal motility or 
nutrient absorption; history of substance abuse or alcoholism; unwilling to restrict consumption 
of specified high polyphenol foods for 24 h before the study; weight change of >3 kg in 
preceding 2 months; body mass index <18 and >35 kg/m2; fasting blood cholesterol ≥7.5 
mmol/L; fasting TAG ≥5 mmol/L; blood pressure ≥160/100 mmHg; current use of medications 
that may interfere with the study such as alpha-glucosidase inhibitors (e.g. acarbose), insulin-
sensitising drugs (e.g. metformin, thiazolidinediones), sulfonylureas, and lipid-lowering drugs; 
current use of nutritional supplements that may interfere with the study such as higher dose 
vitamins/minerals (>200% RNI), B vitamins, Vitamin C, calcium, copper, chromium, iodine, iron, 
magnesium, manganese, phosphorus, potassium and zinc.  
2.2 Study design 
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A randomized, double-blind, crossover design was used to compare 4 test drinks, with study 
visits scheduled at least 1 week apart. Each test drink consisted of a “no added sugar” fruit drink 
with increasing doses of blackcurrant extract added to it, providing 90 kJ, <0.1 g protein, <5 g 
carbohydrate, and 0.4 g fat. The blackcurrant extract (BerryPharma® by Iprona AG, Lana, Italy) 
contained 5775 mg total polyphenols per 100 ml extract (2822 mg total anthocyanins per 100 
ml), analysed by RSSL The Lord Zuckerman Research Centre (Reading, UK); see Table 1. The 
drinks were formulated by Döhler (Milton Keynes, UK) and GlaxoSmithKline Nutritional 
Healthcare R&D (Coleford, UK), later to become Lucozade Ribena Suntory (Uxbridge, UK), and 
standardised to contain 600 mg anthocyanins (H-BE), 300 mg anthocyanins (M-BE) or 150 mg 
anthocyanins (L-BE). The placebo drink did not have any blackcurrant extract added to it 
(CON), but M-BE, L-BE and CON were adjusted with added tannins to ensure blinding by 
making sure each of the drinks had equivalent astringency/bitterness in taste. This meant that 
CON also contained tannin polyphenols. The standardized high carbohydrate meals consumed 
on each study visit consisted of 100 g thick sliced white bread (Hovis, London, UK) with 32 g 
Hartley’s smooth apricot jam (Hain Daniels Group, Leeds, UK), both high carbohydrate foods 
which are low in phenolics (<6 mg/100g fresh weight) [2], to provide 1127 kJ energy, 62 g 
carbohydrate, 39 g starch, 23 g sucrose. The total carbohydrate intake including the test drink 
was 67 g. The randomization schedule was generated by independent contracted parties within 
GlaxoSmithKline Nutritional Healthcare, and allocation to treatment sequence was carried out 
once a participant was determined to be eligible and had agreed to take part in the study 
according to the schedule of randomly generated treatment sequences. Allocation of treatment 
at each visit was blinded from the investigators, laboratory technicians, statisticians and the 
study participants.  
The participants consumed each of the 4 test drinks delivered in opaque bottles and consumed 
with a straw within 2 minutes, in random order, after baseline measurements/blood samples 
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were taken. The mixed carbohydrate meal was consumed immediately after consumption of the 
drink, within 5 min. Each test meal protocol (Figure 1) was separated by at least 1 week.  
On the day preceding each test meal, participants were told not to participate in strenuous 
exercise and to avoid alcohol, caffeine, oily fish, high polyphenol foods (from a list provided) and 
foods high in fat. They were provided with a standardized low-fat meal (containing <10 g fat) as 
their evening meal, which they were required to consume before 20.00 h and then to avoid 
eating or drinking anything except for water until the study visit (a 12 h fast). Participants 
attended the Metabolic Research Unit between 08.00 and 10.30 h the next day. They were 
asked to empty their bladder, be weighed, and then rest in a supine position in a temperature 
controlled, quiet, dim room for 10 min before blood pressure and digital volume pulse (DVP) 
measurements were taken. A cannula was inserted into the forearm antecubital vein, and blood 
was collected for baseline analysis (in duplicate at -15 and -10 min for glucose). Following 
consumption of the test meal, further venous blood samples were collected 10, 20, 30, 45, 60, 
75, 90 and 120 minutes after the test drink/meal for plasma glucose, insulin, NEFA, GIP, GLP-1 
and TAG analysis and at 120 min only for 8-isoprostane F2 analysis. Blood pressure/vascular 
measurements were made within ten minutes after the final blood sample had been taken at 
120 min. Participants had access to water to sip as required over the 2 h period. Adverse 
events were recorded at all study visits where necessary by asking the following question during 
each visit, including any follow-up visits or telephone calls and documenting the reply: “Have 
you felt unwell, experienced any symptoms or taken any medication today or since the last 
session?”. 
2.3 Methods 
Blood samples for plasma GIP and GLP-1 analysis were collected into EDTA tubes (Becton 
Dickinson, UK) and centrifuged at 1300 x g for 15 min at 4 °C and plasma was stored at -80 °C 
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until analysis. EDTA tubes for GLP-1 analysis had 10 µl per ml blood dipeptidyl peptidase IV 
inhibitor added (Millipore, MO, USA). GIP and GLP-1 were determined by ELISA kits (Millipore 
Corporation, MA, USA). Further blood samples were collected into fluoride oxalate tubes for 
glucose analysis and SST™ II tubes for TAG, insulin and NEFA analysis; plasma and serum 
were stored frozen at -40 °C until analysis (Becton Dickinson, UK). Enzymatic assays were 
used to determine concentrations of NEFA, glucose and TAG (TAG and glucose: 
Instrumentation Laboratory, cat.no. 0018255640 and cat.no. 00018250740, Warrington, 
Cheshire, UK; NEFA C: Wako Chemicals GmbH, cat.no. 999-75406, Neuss, Germany) on an 
ILAB-650 analyser (Instrumentation Laboratory, Warrington, UK). Blood for 8-isoprostane-F2α 
analysis was drawn into chilled citrated tubes (Becton Dickinson, UK) and chilled fresh 
indomethacin (cyclooxygenase inhibitor) was immediately added (final concentration 15 
μmol/L). The sample was kept on ice 30 min prior to centrifugation at 2400 × g for 15min.  BHT 
was added (final concentration 20 μmol/L) and the samples were frozen in liquid N2 and stored 
at -80°C until analysis of 8-isoprostane F2α by GC/MS as previously described [21].  
Blood pressure was measured according to British Hypertension Society guidelines using an 
automated upper arm blood pressure monitor, the Omron 705IT (Omron Healthcare Europe 
B.V.). DVP was obtained by photoplethysmography (PulseTrace, Micro Medical Ltd., Kent, UK) 
and used to calculate stiffness index (DVP-SI, m/s) and reflection index (DVP-RI, %).  
2.4 Statistical analyses 
Mean values for plasma glucose concentrations were calculated from duplicate measurements 
made at baseline (-15 and -10 min) before statistical analysis. A linear mixed effects model was 
used to analyse incremental Cmax and AOB using PROC MIXED in SAS software (Marlow, 
UK). Main effects of drink and drink x time interactions for the change from baseline at each 
time point were calculated by linear mixed effects modelling using SPSS Statistics version 21 
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(IBM, UK). The models included subject as a factor (a random effect), fixed factors were drink 
(and time and drink x time interaction where appropriate) and period. Baseline values, and two 
baseline terms were included as covariates: (i) subject-level baseline; the number of valid 
responses calculated as the mean baseline across all periods within a subject, and (ii) the 
period-level baseline minus the subject-level baseline. P-values were adjusted using Dunnett’s 
procedure for the comparison against a control (reference) product, either using SAS for 
incremental Cmax and AOB, or using 2-way repeated measures ANOVA in GraphPad Prism 
version 6.00 for Windows (GraphPad software, CA, USA) for drink and drink x time effects 
(since SPSS does not provide Dunnett’s multiple testing adjustment in the linear mixed model 
facility with repeated measures). The assumption of normality and homogeneity of variance was 
investigated. Violation of these assumptions were overcome where appropriate using natural 
logarithmic transformation. Tmax data was analysed by Friedman’s non-parametric test using 
GraphPad Prism.  
3. Results 
Thirty volunteers who met the initial eligibility criteria following a telephone questionnaire 
attended screening sessions at King’s College London, of whom 4 did not meet inclusion 
criteria. Of the 26 eligible participants, 22 were randomized to treatment and completed the 
study. All completing subjects were fully compliant with the study protocol. Details are shown on 
the consort diagram (Figure 2). The characteristics of those who completed the study are 
shown in Table 2. There were 3 treatment emergent adverse events: one was considered 
treatment-related (discoloured feces following CON) and the others (following H-BE) were 
related to cannulation site discomfort. No adverse events were considered serious.  
3.1 Glucose, insulin and incretins 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
11 
 
 
 
The postprandial changes in plasma glucose after the test drinks and standard carbohydrate 
meals are shown in Figure 3A. An overall drink effect for the change from baseline of 
(Ln)glucose concentrations 0-120 min (P <0.05) was observed, with no statistically significant 
drink x time interaction for postprandial glucose response (P=0.16). As figure 3A illustrates, H-
BE inhibited glucose concentrations during the initial 30 min of the postprandial period (AOB 0-
30 min mean difference H-BE vs CON (95% CI) -0.34 mmol/L.h (-0.56, -0.11, P <0.005); AOB 
0-120 min were not significantly different between meals. Post hoc pairwise comparisons 
showed there were significantly lower glucose concentrations following H-BE compared to CON 
at 10-30 min post-drink (figure 3A), and there was a statistically significant increase in glucose 
following H-BE at 75 min relative to CON (mean difference in change from baseline values was 
0.72 mmol/L (0.18, 1.25; P <0.01). Cmax (adjusted for baseline) was not significantly different 
between meals. Tmax was slightly greater following H-BE (mean at 55 min, 95% CI 48, 62) 
compared to M-BE, L-BE and CON (means were 46 min, 39, 62; 49 min, 42, 57; 48 min, 36, 60, 
respectively) but this did not reach statistical significance (P=0.06). 
There was a statistically significant drink effect (P <0.001) and drink x time interaction (P <0.05) 
for (Ln)insulin 0-120 min, and a drink x time interaction (P <0.05) for the change from baseline 
in (Ln)insulin 0-120 min. Post hoc analysis showed similar temporal drink differences to glucose 
(Figure 3B), with significantly lower insulin concentrations initially, following H-BE compared to 
CON, at 10, 20 and 30 min, and higher concentrations at 75 and 90 min (figure 3B). The mean 
difference in AOB 0-30 min between H-BE and CON (95% CI) was -8.77 mU/L.h; -13.86, -3.68, 
P <0.005. There were no differences in Cmax, Tmax and AOB 0-120 min for insulin.  
Plasma GIP changes from baseline concentration were significantly reduced during the whole 
postprandial measurement period following H-BE anthocyanins compared to CON, with a 
significant decrease in Cmax (mean difference -64.4 ng/L; -95,5, -33.4; P <0.0005) and AOB 0-
120 min (P <0.0001), and highly statistically significant drink effect (P<0.0001) and drink x time 
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interaction (P<0.005) on (Ln)GIP 0-120 min and change from baseline of (Ln)GIP 0-120 min 
(drink effect P<0.0001). Post hoc pairwise comparisons with Dunnett’s adjustment for multiple 
comparisons showing consistently reduced plasma GIP concentrations at all timepoints 
following H-BE up until 90 min (Figure 4A). 
Plasma GLP-1 concentrations were also reduced by H-BE (Figure 4B), with a statistically 
significant drink effect on changes from baseline of (Ln)GLP-1 (P<0.0005), but no significant 
drink x time interaction. Post hoc pairwise comparisons showed reduced plasma GLP-1 
concentrations relative to baseline following H-BE compared to CON and L-BE anthocyanins at 
90 min (figure 4B). There were no differences in Cmax, Tmax and AOB 0-120 min for GLP-1. 
3.2 Lipids 
Plasma TAG concentrations ((Ln)TAG up to 120 min) were significantly different according to 
drink but this was due to a significant difference at baseline (P<0.005) and the changes from 
baseline (Ln)TAG did not differ (Supplementary Figure 1A). There was no effect of drink on 
plasma NEFA concentrations (Supplementary Figure 1B).  
3.3 Isoprostanes and vascular function 
(Ln)8-isoprostane F2concentrations, blood pressure, DVP-SI and DVP-RI changes from 
baseline were not significantly different between drinks (Table 3). 
 
4. Discussion 
This study aimed to investigate whether blackcurrant anthocyanin-rich fruit drinks could inhibit 
the rise in blood glucose concentrations following a high-carbohydrate meal in a healthy 
population. The highest dose of blackcurrant anthocyanins inhibited the rate of the increase in 
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plasma glucose and insulin concentrations in the first 30 min, had an inhibitory effect on plasma 
GIP concentrations up to 90 min post-meal and reduced plasma GLP-1 concentrations at ~90 
min, but the lower doses had no significant inhibitory effects. This delaying effect on 
postprandial glycemia may, if experienced habitually over many years, reduce risk of developing 
insulin resistance and eventually type 2 diabetes [22]. H-BE was equivalent to approximately 
100 g fresh raw blackcurrants [2], which could conceivably be consumed without discomfort at 
one sitting. Furthermore, there tended to be a rebound effect on plasma glucose and insulin 
concentrations in the later time-points, with the highest dose being associated with higher 
concentrations at 75-90 min, as observed previously with whole berry purée and nectar [15, 16]. 
This did not translate to the same pattern in the incretin levels, which consistently showed 
reduced concentrations following the highest dose compared to placebo throughout the 120 min 
postprandial period. No changes in secondary outcome variables related to lipids, vascular 
function or oxidative stress were observed. 
These data are in agreement with previous reports that whole berry meals or berry nectars 
(juices) rich in anthocyanins, including those derived from blackcurrants, inhibited plasma 
glucose and insulin concentrations in the first 30 min following consumption [14, 15, 16, 17, 23]. 
Furthermore, these results provide novel data showing that a liquid blackcurrant extract (devoid 
of fibre and low in other confounding nutrients) not only lowers glucose and insulin 
concentrations, but also inhibits incretin secretion. The observation that GLP-1 secretion may 
be inhibited in the latter half of the postprandial period is in contrast to a previous study of a 
mixed berry meal consumed with sucrose which showed that plasma GLP-1 concentrations 
were slightly increased in the first hour following consumption of the meal [16], which might 
reflect differences in study design such as the solid state of the carbohydrate load, and mixed 
sucrose and starch composition of the present test meal.  
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The difference in carbohydrate type and physical state of the test meal might also explain why a 
previous study observed a return to baseline of insulin concentrations following their reference 
meal (sucrose and water) [15], whereas plasma insulin concentrations remained elevated 
following our control and blackcurrant extract test meals (drink, followed by bread and apricot 
jam). Consequently, the insulin-mediated suppression of circulating NEFA concentrations was 
not different in the current study, in contrast to the previous study which observed an inhibition 
of the upwards return to baseline in plasma NEFA concentrations around 90-120 min following 
blackcurrant puree and blackcurrant juice, in line with higher insulin concentrations at these 
times points in comparison to the reference meal [15]. 
Inhibition of intestinal glucose transporters (e.g. SGLT1, GLUT2) and inhibition of digestive 
enzymes are the primary proposed mechanisms by which blackcurrant polyphenols might act 
on glycaemic response [10, 24, 25], although delayed gastric emptying cannot be ruled out. 
Polyphenolic components of blackcurrant extract such as proanthocyanidins may reduce 
pancreatic -amylase activity in the duodenum by binding to the protein [13]. Additional 
inhibition of carbohydrate digestion may occur by interaction of anthocyanins and other 
blackcurrant polyphenols with intestinal brush border -glucosidases, resulting in reduced 
maltase and sucrase activities [8]. Since our control drink and lower dose intervention drinks 
also contained added tannins in order to match the bitter taste of H-BE, there is likely to have 
been inhibition of -amylase across all test drinks. Thus, differences observed here are possibly 
related to anthocyanin content. Anthocyanins can also be transported into the intestinal cell 
using the SGLT1 transporter, and competition for this route following an anthocyanin-rich meal 
may inhibit rates of glucose absorption, in a similar way to phlorizin (a dihydrochalcone in apple 
that inhibits SGLT1-mediated glucose uptake) [26, 27].  
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The strong inhibition of plasma GIP concentrations throughout the postprandial period suggests 
that secretory regulation of this incretin is highly sensitive to glucose absorption rates. SGLT1 
has been shown to be coexpressed with GLP-1 and GIP in individual enteroendocrine cells of 
murine jejunal crypts, and studies in Sglt1-/- mice have shown the essential role of SGLT1 as a 
glucose sensor for GIP and GLP-1 secretion [28], although GLUT2 may also be an important 
regulator of incretin response [29]. Our human data showing inhibition of carbohydrate-induced 
incretin secretion following consumption of blackcurrant polyphenols mirror previous reports of 
phlorizin sensitivity of glucose-induced SGLT1-mediated incretin release [30].  
The suppression of plasma GLP-1 concentrations by the top dose of blackcurrant extract 
paradoxically coincided with the time point where plasma insulin concentrations were increased 
relative to placebo, at 90 min post-drink. Polyphenol-induced delayed digestive processing of 
the starch/sucrose test meal is likely to have resulted in partially digested dextrins and 
disaccharides possibly shifting further down the small intestine. This may have increased the 
proportion of glucose that was absorbed later (75-90 min) relative to control accounting for the 
crossover in glucose and insulin profiles, in agreement with glycaemic/insulinaemic profiles 
observed previously [15, 16, 17]. GLP-1 is released from L cells in the distal intestine within 
minutes of nutrient ingestion via neuroendocrine signalling, but inhibition by blackcurrant extract 
occurred around the time that the meal contents would be reaching the part of the jejunum 
where the secretory cells are located suggesting a direct inhibition of glucose transport in this 
part of the gut by the blackcurrant polyphenols.  
No acute differences in blood pressure, arterial stiffness or pulse wave reflection index as 
measured by DVP were observed between drinks, consistent with previous vascular 
observations following single meals [31, 32]. This does not exclude the possibility that there 
might be an effect of blackcurrant polyphenols on vascular function. Anthocyanins rapidly 
appear in the circulation1-2 h after consumption at very low concentrations (1-150 nmol/L for 
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intakes of 3-1200 mg) [33, 34], and are equally rapidly cleared, so are unlikely to have a 
significant impact on vascular function early in the postprandial period [35], although 
blackcurrant phenolic acids that peak around 2 h post-ingestion might be associated with some 
improvement in endothelial function [31]. However, colonic metabolites, conjugated phenolic 
acids, would be expected to appear in the circulation 4-12 h post-ingestion, and may also be 
bioactive in this respect [33]. Acute episodes of high blood glucose cause endothelial 
dysfunction in animal models and healthy volunteers in clinical trials, with hyperglycemia-
induced oxidative stress as the most likely mediator [19, 36]. However, the different profiles of 
postprandial glycemia observed here were not associated with any significant differences in a 
sensitive marker of lipid peroxidation, 8-isoprostane F2.  
The strengths of this study include the rigorous adherence to double-blinding until final 
statistical analysis was complete, randomization and allocation concealment being conducted at 
a remote site by an independent party, and the control drink was fully matched to the 
intervention drinks for taste, appearance, and nutrient composition. The study was carried out in 
a broad cross-section of healthy men and postmenopausal women, although premenopausal 
women were excluded to avoid confounding effects of reproductive hormones [37]. Limitations 
of the study include the fact that the difficulty in finding a bitter/astringent taste additive that is 
not a potentially bioactive compound meant that tannins were added to placebo and lower 
doses of blackcurrant extract drinks for taste-blinding. Although we observed significant 
inhibition of glycemia, insulinemia and incretin secretion, the true size of the effect may have 
been much larger if the requirement for blinding had not necessitated addition of tannins. Serum 
concentrations of anthocyanins and their metabolites were not measured in this study since the 
primary aim was to investigate effects on postprandial glycaemia, mainly determined by 
polyphenol interactions with digestive enzymes and intestinal glucose transporters within the 
lumen of the gastrointestinal tract. However, interpretation of some of the secondary outcome 
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variables (vascular function and blood pressure) would have been aided by data on circulating 
blackcurrant polyphenol derivatives. 
In conclusion, anthocyanin-rich blackcurrant extract, providing a similar quantity of polyphenols 
to that found in 5 heaped tablespoons of blackcurrants, delayed the appearance of glucose in 
the blood and inhibited the secretion of insulin and incretins. Although blackcurrants are likely to 
be consumed only sporadically in the general population, other berries contain different profiles 
of anthocyanins. Regular consumption of any combination of these as main meals or with snack 
foods may help lower postprandial glycemia which may reduce the vascular burden of glucose-
induced oxidative stress and endothelial dysfunction [19, 20] involved in the progression of 
atherosclerosis. This evidence supports current dietary advice that a predominantly plant-based 
diet may help prevent CVD and T2D, and suggests one of many routes by which cardio-
metabolic protection can occur.  
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Table 1 Energy, nutrient and polyphenol composition of the test drinks. 
Per 200 ml H-BE M-BE L-BE CON 
Energy and nutrients     
Energy, kJ 92 90 90 95 
Carbohydrate, g 4.6 4.5 4.5 4.8 
Glucose, g 0.2 0.2 0.2 0.2 
Fructose, g 0.2 0.2 0.2 0.2 
Sucrose/Lactose/Maltose, g <0.1 <0.1 <0.1 <0.1 
Starch, g 4.0 4.0 5.0 4.0 
Fat, g 0.4 0.4 0.4 0.4 
Protein, g <0.1 <0.1 <0.1 <0.1 
Total dietary fibre (AOAC), g <0.5 <0.5 <0.5 <0.5 
Vitamin C, mg <0.5 <0.5 <0.5 <0.5 
Vitamin E, mg <0.2 <0.2 <0.2 <0.2 
Sodium, mg <3 <3 <3 <3 
Potassium, mg 15.7 7.8 3.9 <3 
Magnesium, mg 2.3 1.1 0.6 <0.4 
Calcium, mg 6.5 3.3 <3 <3 
Phosphorus, mg <2 <2 <2 <2 
Zinc, mg <0.1 <0.1 <0.1 <0.3 
     
Polyphenols     
Total phenolics, mg1,2 1596 810 460 207 
Total anthocyanins, mg1 599 322 131 46 
Delphinidin-3-rutinoside, mg3 260 140 57 20 
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Cyanidin-3-rutinoside, mg3 209 113 46 16 
Delphinidin-3-glucoside, mg3 76 41 17 6 
Cyanidin-3-glucoside, mg3 33 18 7 3 
H-BE: high blackcurrant extract; M-BE: medium blackcurrant extract; L-BE: low blackcurrant 
extract; CON: no blackcurrant extract. 
1 Total phenolic and anthocyanin content estimated from direct analysis of drinks by Folin-
Ciocalteau method and HPLC respectively.  
2 Tannins added as an ingredient (H-BE 0 mg, M-BE 60 mg, L-BE 90 mg, CON 150 mg per 200 
ml drink) to render drinks equivalent in bitter/astringent taste for blinding purposes. 
3 Estimated from HPLC analysis of raw extract, not direct analysis of the drinks. 
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Table 2 Characteristics of healthy subjects who completed the study (n=22)a. 
Variable  
Age, y 45.4 (13.7) 
Sex, male to female ratio 13:9 
Body Mass Index, kg/m2 25.5 (3.8) 
Systolic blood pressure, mmHg 122.7 (14.1) 
Diastolic blood pressure, mmHg 77.2 (10.8) 
Waist circumference, cm 
Males 
Females 
 
88.3 (9.6) 
89.2 (13.9) 
Body Fat, % 
Males 
Females 
 
18.1 (6.2) 
35.1 (8.2) 
Fasting plasma glucose, mmol/L 5.4 (0.5) 
Fasting plasma triacylglycerol, mmol/L 1.2 (0.5) 
Fasting plasma total cholesterol, mmol/L  4.9 (1.0) 
Fasting plasma LDL cholesterol, mmol/L 2.8 (0.8) 
Fasting plasma HDL cholesterol, mmol/L 
Males 
Females 
1.5 (0.4) 
1.3 (0.4) 
1.7 (0.3) 
aValues are means (SD). 
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Table 3 Effects of blackcurrant extract and placebo test drinks on digital volume pulse (DVP), systolic and diastolic blood pressure (SBP and 
DBP) and plasma 8-isoprostane F2α in healthy men and postmenopausal women.
1 
  CON L-BE M-BE H-BE 
DVP-RI, %  Baseline 74.4 (69.5, 79.2) 70.4 (64.8, 76.1) 72.9 (67.1, 78.6) 72.8 (68.0, 77.5) 
 Δ120 min -0.57 (-5.35, 4.21) 3.80 (-0.93, 8.54) 0.15 (-4.26, 4.56) 1.38 (-3.28, 6.04) 
DVP-SI, m/s Baseline 8.57 (7.75, 9.40) 8.50 (7.63, 9.37) 8.44 (7.64, 9.25) 8.71 (7.62, 9.80) 
 Δ 120 min -0.75 (-1.44, -0.05) -0.23 (-1.05, 0.59) -0.57  (-1.21, 0.07) -0.55 (-1.54, 0.45) 
SBP, mmHg Baseline 120.8 (116.1, 125.2) 120.9 (115.6, 126.0) 120.7 (116.0, 125.5) 118.3 (113.7, 122.9) 
 Δ 120 min -4.5 (-8.8, -0.1) -1.0 (-6.8, 4.9) -5.2 (-8.9, -1.5) -1.7 (-6.7, 3.3) 
DBP, mmHg Baseline 74.6 (71.2, 78.1) 75.3 (71.7, 78.9) 74.5 (71.3, 77.8) 73.6 (70.8, 76.4) 
 Δ 120 min -0.6 (-4.3, 3.2) 1.7 (-2.0, 5.4) -1.1 (-3.6, 1.3) 0.5 (-2.5, 3.5) 
Plasma 8-isoprostane  Baseline 86.4 (68.8, 108.4)3 123.7 (96.6, 158.3) 3 100.5 (80.8, 125.1) 98.4 (76.6, 126.2) 
F2α, pmol/L
2 Δ 120 min 1.13 (1.01, 1.27) 0.94 (0.81, 1.09) 1.02 (0.91, 1.14) 0.97 (0.85, 1.11) 
 
H-BE: high blackcurrant extract (600 mg anthocyanins); M-BE: medium blackcurrant extract (300 mg anthocyanins); L-BE: low 
blackcurrant extract (150 mg anthocyanins); CON: placebo (0 mg anthocyanins). No significant differences were observed between 
drinks. 
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1Values are mean baseline values and changes from baseline measured 120 min after the test drink and mixed carbohydrate meal, (95% CI), 
n=22. 2Values are geometric mean baseline values and log ratios of changes from baseline measured 120 min after the test drink and mixed 
carbohydrate meal, (95% CI), n=22. 3 n=20 due to sample loss. 
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Fig. 1 Study visit protocol 
Fig. 2 Consort diagram 
Figure 3 Postprandial plasma glucose and insulin concentrations 
Mean (±SEM) plasma glucose (A) and insulin (B) concentrations following ingestion of 4 low 
sugar fruit drinks 2 minutes before consuming a mixed carbohydrate meal, in randomized order: 
H-BE: high blackcurrant extract; M-BE: medium blackcurrant extract; L-BE: low blackcurrant 
extract; CON: placebo. N = 22. All data were natural log transformed before mixed model 
analysis. For glucose P < 0.001 for an overall drink effect on changes from baseline, and for 
insulin, P < 0.001 for a drink effect and P < 0.001 for a drink x time interaction on raw values 
and changes from baseline. A: post hoc analysis of time-point differences in change from 
baseline in glucose compared to CON with Dunnett’s adjustment: aP < 0.05 for the difference 
between H-BE and CON and M-BE and CON; bP < 0.005 for the difference between H-BE and 
CON; cP < 0.01 for the difference between H-BE and CON.  B: post hoc analysis of time-point 
differences in change from baseline in insulin with Dunnett’s adjustment: aP < 0.005 for the 
difference between H-BE and CON; bP < 0.01 for the difference between H-BE and CON; cP < 
0.05 for the difference between H-BE and CON. 
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Figure 4 Postprandial plasma GIP and GLP-1 concentrations 
Mean (±SEM) plasma GIP (A) and GLP-1 (B) concentrations following ingestion of 4 low sugar 
fruit drinks 2 minutes before consuming a mixed carbohydrate meal, in randomized order: H-BE: 
high blackcurrant extract (GIP n=17; GLP-1 n=20); M-BE: medium blackcurrant extract (GIP 
n=20; GLP-1 n=22); L-BE: low blackcurrant extract (GIP n=20; GLP-1 n=21); CON: placebo 
(GIP n=19; GLP-1 n=22). All data were natural log transformed before mixed model analysis. 
For GIP, there was an overall drink effect on raw values (P < 0.0001) and changes from 
baseline (P < 0.0001), and a drink x time interaction on raw values (P < 0.005), and for GLP-1 
there was an overall drink effect on raw values and changes from baseline (P < 0.001). A: post 
hoc analysis of time-point differences in change from baseline in GIP with Dunnett’s adjustment: 
aP < 0.0001 for the difference between H-BE and CON, and bP < 0.001 for the difference 
between L-BE and CON; cP < 0.0005 for the difference between H-BE and CON; dP < 0.005 for 
the difference between H-BE and L-BE and H-BE and M-BE; eP < 0.05 for the difference 
between H-BE and CON; and fP < 0.0005 for the difference between H-BE and CON. B: post 
hoc analysis of time-point differences in change from baseline in GLP-1 with Dunnett’s 
adjustment: aP < 0.05 for the difference between H-BE and CON. 
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Figure 1 Study visit protocol 
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Figure 2 Consort diagram. 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
31 
 
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
32 
 
 
 
 
